(Q53644524)

English

Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts. (English)

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Sarah Mccormick

2

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Jonathan L Bramson

9

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

author name string

Janet I Malowany

1

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Michael Santosuosso

3

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Xizhong Zhang

4

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Naoko Aoki

5

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Patricia Ngai

6

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Jun Wang

7

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Jaina Leitch

8

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Yonghong Wan

10

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Zhou Xing

11

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

publication date

15 December 2005

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Molecular Therapy

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

13

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

4

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

766-775

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

Focus: Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Is the development of a new tuberculosis vaccine possible?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Tuberculosis vaccines: the past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Therapy of tuberculosis in mice by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Dendritic-cell control of pathogen-driven T-cell polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Dendritic cells in vaccination therapies of human malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Manipulating dendritic cell biology for the active immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Dendritic cells as a tool to combat infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Peptide-based vaccines for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Modifying adenoviral vectors for use as gene-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Florid pulmonary inflammatory responses in mice vaccinated with Antigen-85 pulsed dendritic cells and challenged by aerosol with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Detailed analysis of the CD8+ T-cell response following adenovirus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Cutting edge: MHC class II-restricted killing in vivo during viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

The host immune response to tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Induction of protective immunity to Listeria monocytogenes with dendritic cells retrovirally transduced with a cytotoxic T lymphocyte epitope minigene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent simian immunodeficiency virus-specific T cell immunity in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.018

7 January 2021

Identifiers

10.1016/J.YMTHE.2005.10.018

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16343993

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53644524&oldid=1790372610"